Stockscreener 앱 받기
31.35
2.03%
-0.65
시장 영업 전:
31.95
0.60
+1.91%
전일 마감가:
$32.00
열려 있는:
$32.16
하루 거래량:
1.10M
Relative Volume:
0.60
시가총액:
$4.98B
수익:
$264.79M
순이익/손실:
$-14.36M
주가수익비율:
-285.00
EPS:
-0.11
순현금흐름:
$-28.11M
1주 성능:
+1.92%
1개월 성능:
+1.10%
6개월 성능:
-16.11%
1년 성능:
+2.15%
1일 변동 폭
$31.14
$32.30
1주일 범위
$29.50
$32.30
52주 변동 폭
$25.28
$46.48
TG테라퓨틱스사 Stock (TGTX) Company Profile
명칭
Tg Therapeutics Inc
전화
(212) 554-4484
주소
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY
TGTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TGTX
Tg Therapeutics Inc
|
31.35 | 5.08B | 264.79M | -14.36M | -28.11M | -0.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
TG테라퓨틱스사 Stock (TGTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-06 | 재개 | H.C. Wainwright | Buy |
| 2025-07-10 | 재개 | Goldman | Neutral |
| 2024-10-29 | 개시 | TD Cowen | Buy |
| 2023-08-02 | 업그레이드 | Goldman | Sell → Neutral |
| 2023-06-26 | 재개 | Jefferies | Buy |
| 2022-05-20 | 개시 | BofA Securities | Underperform |
| 2022-02-23 | 재확인 | B. Riley Securities | Buy |
| 2021-11-15 | 다운그레이드 | Goldman | Neutral → Sell |
| 2021-04-20 | 개시 | Goldman | Neutral |
| 2021-04-19 | 재확인 | H.C. Wainwright | Buy |
| 2020-09-01 | 개시 | JP Morgan | Overweight |
| 2020-08-11 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-05 | 개시 | Evercore ISI | Outperform |
| 2020-01-17 | 재확인 | H.C. Wainwright | Buy |
| 2019-11-27 | 재개 | B. Riley FBR | Buy |
| 2019-02-06 | 재개 | Jefferies | Buy |
| 2018-09-25 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2018-03-09 | 재확인 | B. Riley FBR, Inc. | Buy |
| 2017-12-01 | 재개 | B. Riley FBR, Inc. | Buy |
| 2017-11-14 | 재개 | H.C. Wainwright | Buy |
| 2017-04-25 | 개시 | Jefferies | Buy |
| 2017-03-06 | 재확인 | FBR & Co. | Outperform |
| 2016-10-06 | 재개 | Brean Capital | Buy |
| 2016-05-27 | 개시 | SunTrust | Buy |
| 2015-12-01 | 개시 | FBR Capital | Outperform |
| 2015-09-09 | 개시 | Raymond James | Strong Buy |
| 2015-08-12 | 재개 | H.C. Wainwright | Buy |
| 2015-06-19 | 재확인 | Brean Capital | Buy |
| 2014-12-11 | 재확인 | ROTH Capital | Buy |
| 2014-12-10 | 재확인 | ROTH Capital | Buy |
모두보기
TG테라퓨틱스사 주식(TGTX)의 최신 뉴스
Marex Group plc Makes New $10.02 Million Investment in TG Therapeutics, Inc. $TGTX - MarketBeat
TG Therapeutics (NASDAQ:TGTX) Rating Increased to Buy at Wall Street Zen - MarketBeat
Eventide Asset Management LLC Increases Holdings in TG Therapeutics, Inc. $TGTX - MarketBeat
(TGTX) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
Norges Bank Makes New Investment in TG Therapeutics, Inc. $TGTX - MarketBeat
TG Therapeutics, Inc. $TGTX Shares Bought by Diadema Partners LP - MarketBeat
TG Therapeutics, Inc. $TGTX Shares Acquired by Jump Financial LLC - MarketBeat
Is TG Therapeutics (TGTX) Quietly Reframing Its Investment Story Around Neurology Depth Over Breadth? - Sahm
1832 Asset Management L.P. Has $5.18 Million Stock Holdings in TG Therapeutics, Inc. $TGTX - MarketBeat
TG Therapeutics (NASDAQ:TGTX) Lowered to "Hold" Rating by Wall Street Zen - MarketBeat
Lacklustre Performance Is Driving TG Therapeutics, Inc.'s (NASDAQ:TGTX) Low P/S - 富途牛牛
New York State Common Retirement Fund Boosts Stake in TG Therapeutics, Inc. $TGTX - MarketBeat
TG Therapeutics, Inc. (TGTX) Stock Forecasts - Yahoo Finance
TG Therapeutics, Inc. $TGTX Shares Bought by Russell Investments Group Ltd. - MarketBeat
Is TG Therapeutics Inc. (NKB2) stock nearing a technical breakout2025 Trading Recap & Verified Swing Trading Watchlists - Newser
Is TG Therapeutics Still Attractively Priced After Recent Multiple Sclerosis Expansion Progress? - Sahm
Why TG Therapeutics Inc. (NKB2) stock stays resilient2025 Analyst Calls & Fast Entry High Yield Stock Tips - Newser
TG Therapeutics (TGTX) Earnings Date and Reports 2026 - MarketBeat
TG Therapeutics (TGTX) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
With TG Therapeutics Stock Sliding, Have You Assessed The Risk? - Trefis
Legal & General Group Plc Has $13.18 Million Stock Holdings in TG Therapeutics, Inc. $TGTX - MarketBeat
TG Therapeutics, Inc. $TGTX Shares Acquired by Prudential Financial Inc. - MarketBeat
Rhumbline Advisers Has $14.56 Million Stock Holdings in TG Therapeutics, Inc. $TGTX - MarketBeat
TG Therapeutics, Inc. (NASDAQ:TGTX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Price-Driven Insight from (TGTX) for Rule-Based Strategy - news.stocktradersdaily.com
Is TG Therapeutics Inc NKB2 a good long term investmentGrowth Stock Opportunities & Affordable Investment Portfolio - earlytimes.in
11,012 Shares in TG Therapeutics, Inc. $TGTX Purchased by Inceptionr LLC - MarketBeat
Can Clinical Progress Updates Boost TG Therapeutics' Value in 2025? - Yahoo Finance
11,676 Shares in TG Therapeutics, Inc. $TGTX Bought by Rockefeller Capital Management L.P. - MarketBeat
TG Therapeutics (TGTX): Assessing Valuation and Growth Narrative Following Recent Market Attention - Sahm
TG Therapeutics CEO Michael S. Weiss to Speak at 8th Annual Evercore Healthcare Conference - Quiver Quantitative
TG Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference - The Manila Times
Why TG Therapeutics Inc. stock remains on watchlists2025 Volatility Report & Stepwise Trade Execution Plans - BỘ NỘI VỤ
TG Therapeutics to Participate in the TD Cowen Immunology & Inflammation Summit - Sahm
TG Therapeutics (TGTX) Is Up After Raising 2025 Revenue Guidance Has the Growth Story Strengthened? - Sahm
Can TG Therapeutics Inc. stock surprise with earnings upsideEarnings Trend Report & Fast Entry High Yield Stock Tips - moha.gov.vn
TG Therapeutics TGTX Q3 2025 Earnings Transcript - Nasdaq
Summit Global Investments Purchases Shares of 12,216 TG Therapeutics, Inc. $TGTX - MarketBeat
Rhenman & Partners Asset Management AB Sells 62,500 Shares of TG Therapeutics, Inc. $TGTX - MarketBeat
Director At TG Therapeutics Sells $162K Of Stock - Benzinga
TG Therapeutics Director Sells Shares to Cover Tax Obligations - TradingView
Dir Echelard Sells 5,000 ($162.9K) Of TG Therapeutics Inc [TGTX] - TradingView
TGTX Form 4: Director Yann Echelard stock sale and holdings - Stock Titan
Ensign Peak Advisors Inc Sells 20,900 Shares of TG Therapeutics, Inc. $TGTX - MarketBeat
What macro factors could drive TG Therapeutics Inc. (NKB2) stock higherJuly 2025 Sector Moves & Breakout Confirmation Alerts - newser.com
What insider purchases suggest about TG Therapeutics Inc. (NKB2) stockQuarterly Portfolio Report & Smart Investment Allocation Insights - newser.com
Will TG Therapeutics Inc. stock outperform tech sector in 2025Trade Signal Summary & Daily Oversold Stock Bounce Ideas - newser.com
TG Therapeutics Makes 2025 Deloitte Technology Fast 500 List of America's Fastest-Growing Companies - MarketScreener
Why TG Therapeutics Inc. (NKB2) stock trades below fair valueJuly 2025 Institutional & Momentum Based Trading Ideas - newser.com
TG THERAPEUTICS INC (1TGTX.MI) Stock Price, News, Quote & History - Yahoo! Finance Canada
TG Therapeutics Makes 2025 Deloitte Technology Fast 500™ List of America’s Fastest-Growing Companies - The Globe and Mail
TG테라퓨틱스사 (TGTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.08%
0.91%
자본화:
|
볼륨(24시간):